In Silico Screening of 1,3,4-Thiadiazole Derivatives as Inhibitors of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2)

被引:0
|
作者
Ewell, Steven M. [1 ]
Burton, Hannah [2 ]
Mochona, Bereket [1 ]
机构
[1] Florida A&M Univ, Dept Chem, Tallahassee, FL 32307 USA
[2] Florida A&M Univ, Inst Publ Hlth, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA
基金
美国国家卫生研究院;
关键词
molecular docking; molecular dynamics simulation; virtual screening; Computer-Aided Drug Design (CADD); receptor tyrosine kinases (RTKs); TYROSINE KINASE INHIBITORS; DESIGN; PREDICTION; DISCOVERY;
D O I
10.3390/cimb46100666
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis plays a pivotal role in the growth, survival, and metastasis of solid tumors, with Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) being overexpressed in many human solid tumors, making it an appealing target for anti-cancer therapies. This study aimed to identify potential lead compounds with azole moiety exhibiting VEGFR-2 inhibitory effects. A ligand-based pharmacophore model was constructed using the X-ray crystallographic structure of VEGFR-2 complexed with tivozanib (PDB ID: 4ASE) to screen the ZINC15 database. Following virtual screening, six compounds demonstrated promising docking scores and drug-likeness comparable to tivozanib. These hits underwent detailed pharmacokinetic analysis to assess their absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Furthermore, Density Functional Theory (DFT) analysis was employed to investigate the molecular orbital properties of the top hits from molecular docking. Molecular dynamics (MD) simulations were conducted to evaluate the conformational stability of the complexes over a 100 ns run. Results indicated that the compounds (ZINC8914312, ZINC8739578, ZINC8927502, and ZINC17138581) exhibited the most promising lead requirements for inhibiting VEGFR-2 and suppressing angiogenesis in cancer therapy. This integrated approach, combining pharmacophore modeling, molecular docking, ADMET studies, DFT analysis, and MD simulations, provides valuable insights into the identification of potential anti-cancer agents targeting VEGFR-2.
引用
收藏
页码:11220 / 11235
页数:16
相关论文
共 50 条
  • [21] Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum
    Hempel, Casper
    Hoyer, Nils
    Staalso, Trine
    Kurtzhals, Jorgen A.
    MALARIA JOURNAL, 2014, 13
  • [22] Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum
    Casper Hempel
    Nils Hoyer
    Trine Staalsø
    Jørgen A Kurtzhals
    Malaria Journal, 13
  • [23] Design, microwave assisted synthesis, and molecular modeling study of some new 1,3,4-thiadiazole derivatives as potent anticancer agents and potential VEGFR-2 inhibitors
    Atta-Allah, Saad R.
    AboulMagd, Asmaa M.
    Farag, Paula S.
    BIOORGANIC CHEMISTRY, 2021, 112
  • [24] Calcium enhance mRNA expression of vascular endothelial growth factor receptor (VEGFR) 1, VEGFR-2 and VEGFR-3, but not neuropilins on epidermal keratinocytes
    Man, X.
    Zheng, M.
    Yang, X.
    Cai, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 2 - 2
  • [25] Analysis of Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Glycosylation and its Role in Angiogenesis
    Chandler, Kevin B.
    Khatri, Kshitij
    Leon, Deborah R.
    Meyer, Rosana D.
    Rahimi, Nader
    Costello, Catherine E.
    FASEB JOURNAL, 2016, 30
  • [26] Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies
    Marques, Carolina S.
    Brandao, Pedro
    Burke, Anthony J.
    MOLECULES, 2024, 29 (22):
  • [27] Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
    Rahimi, N
    Dayanir, V
    Lashkari, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) : 16986 - 16992
  • [28] Vascular endothelial growth factor receptor-2 (VEGFR-2) couples with αvβ3 integrin in a ligand dependent manner to promote cell cycle progression.
    Wary, KK
    FASEB JOURNAL, 2001, 15 (04): : A188 - A188
  • [29] Synthesis of some 1,3,4-thiadiazole derivatives as inhibitors of Entamoebahistolytica
    Shadab Miyan Siddiqui
    Attar Salahuddin
    Amir Azam
    Medicinal Chemistry Research, 2013, 22 : 1305 - 1312
  • [30] Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study
    Ewes, Wafaa A.
    Tawfik, Samar S.
    Almatary, Aya M.
    Bhat, Mashooq Ahmad
    El-Shafey, Hamed W.
    Mohamed, Ahmed A. B.
    Haikal, Abdullah
    El-Magd, Mohammed A.
    Elgazar, Abdullah A.
    Balaha, Marwa
    Hamdi, Abdelrahman
    MOLECULES, 2024, 29 (13):